Stock Scorer

Precigen, Inc. (PGEN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 20M 40M 60M Q2 '19: 32.8M Q3 '19: 18.3M Q4 '19: 17M Q1 '20: 29.8M Q2 '20: 30.4M Q3 '20: 23.6M Q4 '20: 19.3M Q1 '21: 24.5M Q2 '21: 3.8M Q3 '21: 3.3M Q1 '22: 5.5M Q2 '22: 2.9M Q3 '22: 16.7M Q4 '22: 1.8M Q1 '23: 1.9M Q2 '23: 1.8M Q1 '25: 1.3M Q2 '25: 856K Q1 '26: 23.3M Q2 '26: 55M Q3 '19 Q2 '20 Q1 '21 Q1 '22 Q4 '22 Q1 '25 Q2 '26

Operating Income Quarterly

-300M -200M -100M 0 100M 200M 300M Q1 '17: -31.4M Q2 '17: -35.3M Q3 '17: -44.7M Q4 '17: -26.5M Q1 '18: -52.7M Q2 '18: -49.7M Q3 '18: -66.5M Q4 '18: -268.1M Q1 '19: -58.7M Q2 '19: -37.4M Q3 '19: -48.6M Q4 '19: -68.7M Q1 '20: -16.6M Q2 '20: -11.8M Q3 '20: -23M Q4 '20: -35.2M Q1 '25: -22.6M Q2 '25: -31.8M Q1 '26: -6M Q2 '26: 22.6M Q2 '17 Q1 '18 Q4 '18 Q3 '19 Q2 '20 Q1 '25 Q2 '26

Net Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '21: -29.8M Q4 '21: -25M Q1 '22: -19.3M Q2 '22: -17.6M Q3 '22: 87.4M Q4 '22: -22.2M Q1 '23: -22.7M Q2 '23: -20.3M Q3 '23: -19.8M Q4 '23: -33.1M Q1 '24: -23.7M Q2 '24: -58.8M Q3 '24: -24M Q4 '24: -19.7M Q1 '25: -54.2M Q2 '25: -26.6M Q3 '25: -146.3M Q4 '25: -23.5M Q1 '26: -7.9M Q2 '26: 20.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '21: -17M Q4 '21: -14.6M Q1 '22: -18.8M Q2 '22: -7.1M Q3 '22: -23.8M Q4 '22: -15.4M Q1 '23: -18.4M Q2 '23: -15.8M Q3 '23: -17M Q4 '23: -15.8M Q1 '24: -14.1M Q2 '24: -23.1M Q3 '24: -22.7M Q4 '24: -8.2M Q1 '25: -16.3M Q2 '25: -19M Q3 '25: -29.1M Q4 '25: -23.5M Q1 '26: -43.8M Q2 '26: -17.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '21: -19.3M Q4 '21: -17.4M Q1 '22: -20.4M Q2 '22: -8.8M Q3 '22: -25.4M Q4 '22: -15.4M Q1 '23: -18.5M Q2 '23: -15.9M Q3 '23: -17.2M Q4 '23: -16.8M Q1 '24: -18.4M Q2 '24: -25.4M Q3 '24: -23.6M Q4 '24: -9.3M Q1 '25: -16.9M Q2 '25: -19.9M Q3 '25: -29.5M Q4 '25: -23.5M Q1 '26: -44.1M Q2 '26: -18.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q1 '20: 160.3M Q2 '20: 164.1M Q3 '20: 165.5M Q1 '21: 193.5M Q2 '21: 199M Q3 '21: 199.2M Q1 '22: 199.6M Q2 '22: 200.5M Q3 '22: 200.7M Q1 '23: 229.8M Q2 '23: 248M Q3 '23: 248.5M Q1 '24: 249.2M Q2 '24: 252.4M Q3 '24: 275.9M Q1 '25: 293.9M Q2 '25: 296.4M Q3 '25: 307.2M Q1 '26: 354.3M Q2 '26: 413.7M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Q3 '21: -0.57 Q4 '21: -0.47 Q1 '22: -0.48 Q2 '22: -0.47 Q3 '22: 0.12 Q4 '22: 0.14 Q1 '23: 0.14 Q2 '23: 0.15 Q3 '23: -0.37 Q4 '23: -0.39 Q1 '24: -0.39 Q2 '24: -0.54 Q3 '24: -0.55 Q4 '24: -0.48 Q1 '25: -0.56 Q2 '25: -0.42 Q3 '25: -1.39 Q4 '25: -1.34 Q1 '26: -1.18 Q2 '26: -1.04 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for PGEN: Gross Profit, Cost of Revenue. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.